Kopp Drug Selects Activant Eagle Solution

LIVERMORE, Calif., Aug. 30 /PRNewswire/ -- Activant Solutions Inc., a leading provider of retail and distribution business management solutions, today announced that Kopp Drug Inc. has selected the Activant Eagle® software platform to be its business management and Point-of-Sale (POS) solution. Kopp executives selected the Activant Eagle solution to help them improve inventory management and add operational efficiencies.  

In business since 1925, Kopp Drug is an independent community pharmacy chain with 10 locations throughout central Pennsylvania. Frustrated with their previous system's inability to effectively manage inventory and handle flexible spending account (FSA) card transactions, Kopp executives began evaluating new POS solutions earlier this year. They were immediately impressed with the thoroughness and professionalism exhibited by the Activant sales team.

"At Kopp Drug, we pride ourselves on outstanding personalized service. In Activant, we have found a technology partner that clearly shares this focus," said William Earnest, Chief Operating Officer of Kopp Drug. "I have had many meetings with software and hardware vendors, and I have never met an organization that analyzed my business as thoroughly as Activant. They took the time to really understand our business and our needs before making their first recommendations."

The pharmacy marketplace is undergoing a major shift, and pharmacy owners are being forced to improve their retail systems and practices in order to survive. Independent community pharmacies are looking for ways to expand their retail business and become a primary shopping destination. For these pharmacies, this translates into having an extensive mix of merchandise, pricing these products competitively and having them readily available to customers. Kopp Drug executives selected the Activant Eagle system to elevate each of these critical functions.  

"We are looking to increase our overall sales and profitability with the help of the Eagle system's advanced inventory controls.  We plan to use the Activant Eagle solution to provide complete inventory visibility and control across our 10 stores," added Earnest. The Eagle reporting and analytics tools are designed to give Kopp executives real-time insight into stock levels and aid in making better buying decisions. Kopp's clerks will also have improved inventory visibility and will be able to access and sell inventory from other Kopp store locations.

Kopp Drugs uses the QS-1 pharmacy management software solution to run its back of store Rx business. In selecting a pharmacy retail POS system, they wanted a solution that would readily integrate with the QS-1 software. Activant has already developed and successfully implemented a data bridge to the QS-1 software.

"Being a successful retailer is about having the right merchandise, in the right place, at the right time," said Scott Hanson, Senior Vice President of Sales for Activant. "Activant is very proud to be working with Kopp Drug to help them manage their impressive inventory, while also giving them the tools to elevate their retail operations and decision-making."

About Activant Solutions

Activant Solutions Inc. is a leading technology provider of business management solutions serving small- and medium-sized businesses in three primary vertical markets: hardware and lumber, wholesale distribution and the automotive parts aftermarket.  Activant provides customers with industry specific software, professional services, content, supply chain connectivity, and analytics.  Over 30,000 customer locations use Activant to manage their day-to-day operations.  Activant's systems are designed to help customers increase sales, boost productivity, operate more cost-efficiently, improve inventory turns and enhance trading partner relationships.  Activant has operations in Texas, California, Colorado, Illinois, Pennsylvania, South Carolina, Utah, Canada, Ireland and the United Kingdom.  For more information, please visit www.activant.com.

This announcement relating to Activant may contain statements that are forward looking within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, such as statements concerning trends, future technology or products, or Activant's execution. These statements are based on current expectations and are subject to risks and uncertainties which could materially affect the company's results, including, without limitation, market demand for products and technology, the company's ability to meet that market demand, the integration of Activant's technology and products with technology and products supplied by others, the integration of Activant's products into the businesses of its customers, customer acceptance of Activant's products, and the retention and deployment of skilled Activant service providers. Except to the extent required by applicable securities laws, we undertake no obligation to update or publicly revise any of the forward-looking statements. Please refer to our most recently filed Quarterly Report on Form 10-Q for the period ended June 30, 2010 and our Annual Report on Form 10-K for the year ended September 30, 2009, each of which have been filed with the Securities Exchange Commission and can be found through the Activant investor relations website at www.activant.com/company/investors for a full discussion of the risks and other factors.

Note: Activant, Activant Eagle, Eagle, and the stylized Activant logo design are registered trademark of Activant Solutions Inc. All other trademarks are the property of their respective owners.

SOURCE Activant Solutions Inc.